Design and synthesis of vidarabine prodrugs as antiviral agents

Design and synthesis of vidarabine prodrugs as antiviral agents Synthesis and antiviral effect of phosphamide modified vidarabine for treating HSV 1 infections Prodrugs of 9-.beta.-D-arabinofuranosyladenine. 1. Synthesis and evaluation of some 5'-(O-acyl) derivatives Phosphoramidates of 2′-β-d-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism New prodrugs of two pyrimidine acyclic nucleoside phosphonates: Synthesis and antiviral activity Synthesis and antiviral activity of amino acid esters of ribavirin Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA Simple mono-derivatisation of the aryl moiety of D4A and DDA-based phosphoramidate prodrugs significantly enhances their anti-HIV potency in cell culture Synthesis and antiviral activity of acyclovir-5′-(phenyl methoxy alaninyl) phosphate as a possible membrane-soluble nucleotide prodrug PMPA and PMEA prodrugs for the treatment of HIV infections and human papillomavirus (HPV) associated neoplasia and cancer